<VariationArchive VariationID="525139" VariationName="NC_000011.10:g.(?_47332546)_(47334030_?)del" VariationType="Deletion" Accession="VCV000525139" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2018-05-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="525997" VariationID="525139">
      <GeneList>
        <Gene Symbol="MYBPC3" FullName="myosin binding protein C3" GeneID="4607" HGNC_ID="HGNC:7551" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="47331406" stop="47352702" display_start="47331406" display_stop="47352702" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="47352956" stop="47374252" display_start="47352956" display_stop="47374252" Strand="-" />
          </Location>
          <OMIM>600958</OMIM>
          <Haploinsufficiency last_evaluated="2023-01-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MYBPC3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-01-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MYBPC3">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NC_000011.10:g.(?_47332546)_(47334030_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" innerStart="47332546" innerStop="47334030" display_start="47332546" display_stop="47334030" variantLength="1485" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" innerStart="47354097" innerStop="47355581" display_start="47354097" display_stop="47355581" variantLength="1485" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.(?_47332546)_(47334030_?)del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.(?_47332546)_(47334030_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.(?_47354097)_(47355581_?)del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.(?_47354097)_(47355581_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000011.10:g.(?_47332546)_(47334030_?)del AND Hypertrophic cardiomyopathy" Accession="RCV000629176" Version="5">
        <ClassifiedConditionList TraitSetID="17368">
          <ClassifiedCondition DB="MedGen" ID="C0007194">Hypertrophic cardiomyopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-09-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-09-29" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-05-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16335287</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19574547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20433692</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23396983</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28771489</ID>
        </Citation>
        <DescriptionHistory Dated="2022-05-15">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="17368" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="22501" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypertrophic cardiomyopathy</ElementValue>
                <XRef ID="HP:0001639" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005045" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERTROPHIC MYOCARDIOPATHY</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="20518" />
                <XRef ID="20518" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="217569" DB="Orphanet" />
              <XRef ID="C0007194" DB="MedGen" />
              <XRef ID="D002312" DB="MeSH" />
              <XRef ID="MONDO:0005045" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001639" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1459439" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="NM_000256.3_11_Deletion (exons 28-32)|MedGen:C0007194" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000750092" DateUpdated="2024-06-09" DateCreated="2018-05-28" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19574547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16335287</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23396983</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28771489</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20433692</ID>
          </Citation>
          <Comment>This variant results in the deletion of exon(s) 29-32 and part of exon 28 (c.2962_3628-150del) of the MYBPC3 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in MYBPC3 are known to be pathogenic (PMID: 19574547). This variant disrupts the p.Arg1022 amino acid residue in MYBPC3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16335287, 23396983, 28771489, 20433692). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. This variant has not been reported in the literature in individuals with MYBPC3-related conditions.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.(?_47354097)_(47355581_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0007194" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB3864685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1459439" TraitType="Disease" MappingType="XRef" MappingValue="C0007194" MappingRef="MedGen">
        <MedGen CUI="C0007194" Name="Hypertrophic cardiomyopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

